One year data from a phase 2b trial of AMT-061 (AAV5-Padua hFIX variant), An enhanced vector for gene transfer in adults with severe or moderate-severe hemophilia B

Authors
Category Primary study
JournalHaemophilia
Year 2020
This article has no abstract
Epistemonikos ID: 298eda0734d1a9898819aa25644ece39497408a6
First added on: Feb 11, 2025